Evidence shows reductions in fluoroscopy time and radiation exposure of up to 90%
Cardiac Resynchronization Therapy (CRT) device implantations are often associated with high radiation dose exposure due to long procedure and fluoroscopy times.
A first in human study recently conducted at the Heart Centre Leipzig (Germany) proved the benefits of using a novel sensor-based MediGuide™ Technology (St. Jude Medical Inc., St. Paul, MN) in combination with the Artis zee angiography system (Siemens Healthcare, Forchheim, Germany) for CRT implantations [1].
The study showed reductions fluoroscopy time and radiation exposure of up to 90% when compared to conventional (exclusively fluoroscopy-guided) CRT implantations. There were no negative consequences on procedural efficacy and no complications.